These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6304182)

  • 21. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of aspirin and enteric-coated aspirin on loss of chromium 51-labeled erythrocytes from the gastrointestinal tract.
    Robbins DC; Schwartz RS; Kutny K; Vallejo G; Horton ES; Cotter JM
    Clin Ther; 1984; 6(4):461-6. PubMed ID: 6331883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of aspirin and ethanol on fecal blood levels as determined by using the HemoQuant assay.
    Fleming JL; Ahlquist DA; McGill DB; Zinsmeister AR; Ellefson RD; Schwartz S
    Mayo Clin Proc; 1987 Mar; 62(3):159-63. PubMed ID: 3821177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint.
    Doubilet P; Donowitz M; Pauker SG
    Med Decis Making; 1982; 2(2):147-60. PubMed ID: 7167043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
    Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
    Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of HemoQuant assays to assess the effect of oral iron preparations on stool hemoccult tests.
    Coles EF; Starnes EC
    Am J Gastroenterol; 1991 Oct; 86(10):1442-4. PubMed ID: 1928035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
    Harewood GC; McConnell JP; Harrington JJ; Mahoney DW; Ahlquist DA
    Mayo Clin Proc; 2002 Jan; 77(1):23-8. PubMed ID: 11794453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 tablets prevent aspirin-induced blood loss in man.
    Yik KY; Dreidger AA; Watson WC
    Dig Dis Sci; 1982 Nov; 27(11):972-5. PubMed ID: 6982803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fecal blood loss after use of aspirin and diflunisal.
    Rider JA
    Pharmacotherapy; 1983; 3(2 Pt 2):61S-64S. PubMed ID: 6602328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,300 mg of aspirin daily.
    Segal HL
    J Clin Gastroenterol; 1983 Dec; 5(6):553-4. PubMed ID: 6607274
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
    Allison JE; Feldman R; Tekawa IS
    Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of achlorhydria on aspirin-induced occult gastrointestinal blood loss: studies in Addisonian pernicious anaemia.
    John DJ; McDermott FT
    Br Med J; 1970 May; 1(5707):450-2. PubMed ID: 4911773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of immunochemical fecal occult blood tests among users of low-dose aspirin.
    Chan YH; Schooling CM
    JAMA; 2011 Mar; 305(11):1093; author reply 1093-4. PubMed ID: 21406642
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimal dietary conditions for hemoccult testing.
    Macrae FA; St John DJ; Caligiore P; Taylor LS; Legge JW
    Gastroenterology; 1982 May; 82(5 Pt 1):899-903. PubMed ID: 7060911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction.
    Bassett ML; Goulston KJ
    Aust N Z J Med; 1980 Feb; 10(1):1-4. PubMed ID: 6966493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
    Morini S; Manurita L; Stroppa I; Bassi O
    Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation into the effects of oral iron supplementation on in vivo Hemoccult stool testing.
    Anderson GD; Yuellig TR; Krone RE
    Am J Gastroenterol; 1990 May; 85(5):558-61. PubMed ID: 2186616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans.
    Kahi CJ; Imperiale TF
    Am J Med; 2004 Dec; 117(11):837-41. PubMed ID: 15589487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ingestion of hemoproteins on fecal excretion of hemes and porphyrins.
    Rose IS; Young GP; St John DJ; Deacon MC; Blake D; Henderson RW
    Clin Chem; 1989 Dec; 35(12):2290-6. PubMed ID: 2556222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.